Indonesia’s largest privately owned pharmaceutical company PT Kalbe Farma Tbk (KLBF) and state-controlled PT Kimia Farma Tbk (KAEF) have decided to develop new plant to produce pharmaceutical raw materials in a move to reduce dependence on imported raw materials.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
